Discovery and molecular characterization of West Nile virus NY1999

Viral Immunology

Volumn 13, Issue 4, 2000, Pages 435-446

  Jordan, I ^a   Briese, T ^a   Lipkin, W I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATE; IMMUNOGLOBULIN M; NUCLEOSIDE ANALOG; PIRAZOFURIN; PYRIMIDINE; RIBAVIRIN; VIRUS DNA; VIRUS RNA;

ANTIVIRAL ACTIVITY; CYTOPATHOGENIC EFFECT; DRUG EFFICACY; EPIDEMIC; FEVER; GENETIC ANALYSIS; HEADACHE; HEMOLYTIC ANEMIA; HUMAN; MYALGIA; MYOCARDITIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREATITIS; RASH; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SERODIAGNOSIS; VIRUS CHARACTERIZATION; VIRUS INFECTION; VIRUS ISOLATION; VIRUS STRAIN; WEST NILE FLAVIVIRUS;

EID: 0034505914     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2000.13.435     Document Type: Review

References (93)

1. Glycosylation and antigenic variation among Kunjin virus isolates
2. A case of West Nile myocarditis
3. Isolation of West Nile virus from mosquitoes, crows, and a Cooper's hawk in Connecticut
4. Outbreak of West Nile-like viral encephalitis - New York, 1999
5. The West Nile virus outbreak of 1999 in New York: The Flushing Hospital experience
6. Extensive nucleotide changes and deletions within the envelope glycoprotein gene of Euro-African West Nile viruses
7. Detection of West Nile virus sequences in cerebrospinal fluid
8. Identification of a Kunjin/West Nile-like flavivirus in brains of patients with New York encephalitis
9. Clinical, biological, and biochemical effect of pyrazofurin
10. Antigenic classification and taxonomy of flaviviruses (family Flaviviridae) emphasizing a universal system for the taxonomy of viruses causing tick-borne encephalitis
11. Mechanism of La Crosse virus inhibition by ribavirin
12. Update: West Nile virus isolated from mosquitoes - New York, 2000
13. West Nile virus envelope proteins: Nucleotide sequence analysis of strains differing in mouse neuroinvasiveness
14. Intravenous ribavirin for hantavirus pulmonary syndrome: Safety and tolerance during 1 year of open-label experience
15. Use of NS3 consensus primers for the polymerase chain reaction amplification and sequencing of dengue viruses and other flaviviruses
16. Safety, tolerance, and pharmacokinetics of systemic ribavirin in children with human immunodeficiency virus infection
17. Update: Surveillance for West Nile virus in overwintering mosquitoes - New York, 2000
18. Strain analysis and epitope mapping of West Nile virus using monoclonal antibodies
19. Prevalence of antibodies to arboviruses in Egypt: Results of a serologic survey among 1,113 university students
20. Interferon Alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C
21. Tolerance and antiviral effect of ribavirin in patients with Argentine hemorrhagic fever
22. Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate
23. Determination of human IgG and IgM class antibodies to West Nile virus by enzyme linked immunosorbent assay (ELISA)
24. Update: West Nile virus encephalitis - New York, 1999
25. Update: West Nile-like viral encephalitis - New York, 1999
26. West Nile fever encephalitis
27. Studies on antigenic pecularities of West Nile virus strains isolated in the U.S.S.R. by three serological tests
28. Isolation of West Nile virus from brains of children who had died of encephalitis
29. The natural history of West Nile fever. II. Virological findings and the development of homologous and heterologous antibodies in West Nile infection in man
30. West Nile fever. The clinical features of the disease and the isolation of West Nile virus from the blood of nine human cases
31. The broad spectrum antiviral agent ribavirin inhibits capping of mRNA
32. Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study
33. Antigenic variations of West Nile virus in relation to geography
34. Family Flaviviridae
35. Kinetic PCR analysis: Real-time monitoring of DNA amplification reactions
36. Detection of specific polymerase chain reaction product by utilizing the 5′ ± 3′ exonuclease activity of Thermus aquaticus DNA polymerase
37. West Nile fever - A reemerging mosquito-borne viral disease in Europe
38. Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug
39. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome
40. West Nile virus infection in arthropods
41. Genetic analysis of West Nile New York 1999 encephalitis virus
42. Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells
43. Detection of West Nile virus in field samples by reverse transcriptase-polymerase chain reaction
44. Broad-spectrum antiviral activity of 2-beta-D-ribofuranosylselenazole-4-carboxamide, a new antiviral agent
45. Certain aspects of the epidemiology and distribution of immunity of West Nile virus in Israel
46. Phylogeny of the genus flavivirus
47. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States
48. Allelic discrimination by nick-translation PCR with fluorogenic probes
49. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization
50. The natural history of West Nile fever. I. Clinical observations during an epidemic in Israel
51. Lassa fever. Effective therapy with ribavirin
52. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
53. Epidemics of West Nile and Sindbis viruses in South Africa with Culex (Culex) univittatus Theobald as vector
54. Ecological studies on Sindbis and West Nile viruses in South Africa. IV. Infection in a wild avian population
55. Treatment of severe La Crosse encephalitis with intravenous ribavirin following diagnosis by brain biopsy
56. The molecular basis of virulence of the encephalitogenic flaviviruses
57. A comparison of the spread of Murray Valley encephalitis viruses of high or low neuroinvasiveness in the tissues of Swiss mice after peripheral inoculation
58. Mode of entry of a neurotropic arbovirus into the central nervous system. Reinvestigation of an old controversy
59. Immunoglobulin M antibody capture enzyme-linked immunosorbent assay for diagnosis of St. Louis encephalitis
60. Factors in the emergence of infectious diseases
61. Subacute measles encephalitis in the young immunocompromised host: Report of two cases diagnosed by polymerase chain reaction and treated with ribavirin and review of the literature
62. Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response
63. Arbovirus activity in Israel
64. Update: West Nile virus activity - Northeastern United States, January-August 7, 2000
65. Antiviral activity of virazole on replication of viruses isolated in Nigeria. Current Chemotherapy
66. Phase and cell cycle specificity of pyrazofurin action
67. Epidemiologie du virus West Nile. Etude d'un foyer en Camargue. III. Les maladies humaines
68. Acute pancreatitis in West Nile fever
69. Identification of mosquito-borne flavivirus sequences using universal primers and reverse transcription/polymerase chain reaction
70. Detection of West Nile virus by the polymerase chain reaction and analysis of nucleotide sequence variation
71. Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
72. A new class of synthetic nucleoside analogues with broad-spectrum antiviral properties
73. Migratory birds and spread of West Nile Virus in the Western Hemisphere
74. Potential effect of global warming on mosquito-borne arboviruses
75. Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C
76. Entomologic and avian investigations of an epidemic of West Nile fever in Romania in 1996, with serologic and molecular characterization of a virus isolate from mosquitoes
77. Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
78. Ribavirin: An antiviral agent
79. A neurotropic virus isolated from the blood of a native of Uganda
80. Induced virus infections in man by the Egypt isolates of West Nile virus
81. Clinical and laboratory observations in an outbreak of West Nile fever in Israel in 1957
82. Pathology of fatal West Nile virus infection in native and exotic birds during the 1999 outbreak in New York City, New York
83. Mechanism of action of 1-β-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent
84. Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants
85. Ribavirin polarizes human T cell responses towards a type 1 cytokine profile
86. Rapid identification of flavivirus using the polymerase chain reaction
87. A study of the ecology of West Nile virus in Egypt
88. Indigenous wild birds of the Nile Delta as potential West Nile virus circulating reservoirs
89. Effect of ribavirin triphosphate on primer generation and elongation during influenza virus transcription in vitro